Dextromethorphan and guaifenesin use really should be monitored diligently in sufferers with "poor metabolizer" CYP2D6 enzyme concentrations and people who're sedated. This combination medication includes a massive median poisonous dose (TD50) to median successful dose (ED50) ratio (or therapeutic index) in these individuals. We only use top quality, credible resources https://chemicalglobe.com/shop/dxm/buy-dxm-powder-online/